Plasmid DNA Purification via Core Bead Flow-Through Chromatography
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for purifying plasmid DNA (pDNA) struggle to produce high yields of highly pure pDNA suitable for pharmaceutical applications, particularly for producing RNA molecules like mRNA or self-amplifying mRNA (SAM) that encode therapeutic or immunogenic peptides or proteins.
Innovation Solution
A method for purifying pDNA that involves optimizing the process to produce high quantity and quality yields, specifically using a combination of core bead flow-through chromatography and anion exchange chromatography to separate and purify supercoiled pDNA, thereby reducing impurities and enhancing the purity of the final product.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If conventional purification methods are used, then the process is simpler, but the purity and yield of pDNA are insufficient for pharmaceutical applications
Solution Approach 1:
The purification process is divided into distinct sequential steps: core bead flow-through chromatography followed by anion exchange chromatography. Each step targets specific impurities, with the first step removing proteins and endotoxins, and the second step separating supercoiled pDNA from open circular DNA and other contaminants. This segmentation allows each purification step to be optimized independently, achieving pharmaceutical-grade purity while maintaining process manageability.
Solution Approach 2:
The patent introduces core bead flow-through chromatography as an intermediary step between cell lysis and traditional anion exchange chromatography. This intermediate purification step pre-cleans the lysate by removing proteins and endotoxins through size exclusion and binding properties, thereby improving the performance of the subsequent anion exchange step and enabling higher final purity without excessive complexity.
2Manufacturing precision
If multiple purification steps are added to increase purity, then pDNA purity improves, but processing time and complexity increase
Solution Approach 1:
The core bead flow-through chromatography step operates in flow-through mode where the mobile phase continuously passes through the column, allowing rapid removal of proteins and endotoxins without requiring multiple washing or elution cycles. This continuous action maintains high purification efficiency while minimizing processing time, and the effluent is directly ready for the next anion exchange step without intermediate handling.
3Object-generated harmful factors
If core bead flow-through chromatography is used, then removal of proteins and endotoxins is enhanced, but the process complexity increases
Solution Approach 1:
Core bead chromatography media with controlled porosity and pore size distribution are used to achieve size exclusion of proteins and endotoxins. The porous structure allows small molecules and proteins to enter and bind within the pores while excluding larger pDNA molecules, providing effective removal of harmful contaminants through the inherent physical properties of the porous material rather than complex chemical mechanisms.
4Manufacturing precision
If anion exchange chromatography is optimized for supercoiled DNA separation, then the ratio of supercoiled to open circular DNA increases, but the number of process steps increases
Solution Approach 1:
The anion exchange chromatography step utilizes controlled changes in ionic strength and pH of the mobile phase to selectively elute different DNA conformations. By optimizing the gradient profile and buffer conditions, supercoiled DNA is preferentially retained and then eluted at specific conditions, achieving high supercoiled to open circular DNA ratios. This parameter optimization allows a single chromatography step to perform the separation function that would otherwise require multiple steps.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method achieves high-purity pDNA with a significant reduction in non-pDNA materials, improving the ratio of supercoiled plasmid DNA to open circular DNA, and ensuring the pDNA is suitable for downstream applications such as mRNA production for vaccines.
Implementation Method 1
subjecting a sample comprising pDNA to a core bead flow-through chromatography step to reduce the level of at least endotoxin
Implementation Method 2
core bead flow-through chromatography removes materials by both size exclusion and binding properties
Implementation Method 3
subjecting the core bead flow-through to an anion exchange chromatography step
Data Source
AI summary
This application discloses a method for purifying pDNA, particularly pDNA that that can be used to produce RNA, the RNA preferably encoding a therapeutic or immunogenic peptide or polypeptide. The pDNA can be grown in a bacteria such as E. coli by culturing or fermenting bacteria containing the plasmid and obtaining and purifying the pDNA. The present method allows the pDNA to be obtained in high yield and with high purity. In one embodiment of the invention, the level of all non-pDNA materials can be significantly reduced by the process. In some embodiments, the ratio of supercoiled plasmid DNA (scDNA) to non-supercoiled pDNA (non-scDNA, such as open circular plasmid DNA (ocDNA)) can be increased by one or more process steps that separate or allow for separation of scDNA and ocDNA or process steps that increase the amount of scDNA to ocDNA.